Cargando…
Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial
BACKGROUND: We aimed to evaluate the effects of short-term therapy with dapagliflozin on serum uric acid (SUA) and urinary uric acid (UUA) levels in patients with type 2 diabetes. METHODS: In this prospective pilot trial, 8 patients with type 2 diabetes mellitus were assigned to the treatment group...
Autores principales: | Yuan, Tao, Liu, Shixuan, Dong, Yingyue, Fu, Yong, Tang, Yan, Zhao, Weigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590796/ https://www.ncbi.nlm.nih.gov/pubmed/33117454 http://dx.doi.org/10.1186/s13098-020-00600-9 |
Ejemplares similares
-
Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study
por: Wang, Shihan, et al.
Publicado: (2022) -
The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
por: Iwata, Yukimasa, et al.
Publicado: (2023) -
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study
por: Stack, Austin G, et al.
Publicado: (2020) -
Effects of dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial
por: Hao, Zhaohu, et al.
Publicado: (2018) -
Urinary proteomic analysis during pregnancy and its potential application in early prediction of gestational diabetes mellitus and spontaneous abortion
por: Wang, Xiangqing, et al.
Publicado: (2022)